• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Problematic ME/CFS research on ACT/GET in Sweden

mango

Senior Member
Messages
905
On page 98 there's another study by the same people: "Exploring symptom subgroups in patients with ME/CFS"

Jonsjö M, Wicksell RK, Holmström L, Andreasson A, Ljungar I, Olsson GL

ETA:
Exploring symptom subgroups in patients with ME/CFS

Jonsjö M, Wicksell RK, Holmström L, Andreasson A, Ljungar I, Olsson GL

Dept. of Behavior Medicine, Karolinska University Hospital, Dept. of Physiology & Pharmacology; Dept. of Clinical Neuroscience; Dept. of Women's and Children's Health; Dept. of Neurobiology, Care Sciences and Society; Dept. of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden

Background: It is still not clear whether the diagnosis Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) represents one single disease entity, as diagnosis depends on clinical case definitions. The heterogeneity and variation of symptoms across individuals indicate possible differences in the relations between symptoms, and their impact on fatigue, mood, functioning and quality of life. To advance the knowledge of the relative importance of different symptoms, the investigation of relations between symptoms among patients with ME/CFS would be of great value.

Objectives
The present study examines the relations between symptoms in patients diagnosed with ME/CFS, to identify possible symptom subgroups and their relations to functioning and quality of life.

Methods
Data was collected from 106 adults as part of the standard assessment at a tertiary specialist clinic for ME/CFS. All included patients fulfilled the 1994 CDC and 2003 Canadian criteria for ME/CFS and were thus included in this study. All participants presented with longstanding unexplained fatigue, post-exertional malaise and symptom increase after activity as well as prolonged recovery period after mental, physical or emotional effort.

Patients reported occurrence and severity of 14 different symptoms (Tender lymph nodes; Palpitations; Feverishness; Orthostatic dizziness; Irritable bowel; Sleep dysfunction; Numbness and paraesthesia; Joint pain; General pain; Body soreness; Difficulty concentrating; Memory problems; Chills and perspirations and; Headache). Symptoms were chosen based on the 2003 case definition (i.e. the Canadian criteria) and our clinical experience of the most commonly presented symptoms by patients. Data were analysed using principal component (PCA) and correlation analyses.

Results
The poster will present results from PCA as well as relationships between symptom subgroups and other clinical factors of importance. Principal component analyses suggested four clinically meaningful and statistically distinct subgroups of symptoms. Analyses of the relations between symptom subgroups and measures of fatigue, mood, functioning and quality of life showed large differences in strength, indicative of dif
ferences in impact of symptom subgroups.

Conclusions
The results from this study further the understanding of symptom relations. The identification of symptom subgroups could be a first step towards a more systematic approach in investigating possible differences in aetiology between patients, as well as tailoring treatments depending on illness profile.

Martin Jonsjö, PhD student.
Dept. of Physiology & Pharmacology, Karolinska Institutet
Behavior Medicine, Department of Anesthesiology & Intensive Care
P8:01, Karolinska University Hospital, SE-171 76 Stockholm, Sweden

http://iacfsme.org/ME-CFS-Primer-Education/News/IACFSME-2016-Program.aspx
 
Last edited:

mango

Senior Member
Messages
905

mango

Senior Member
Messages
905
Here's another related(?) study protocol:

Comparing group-based acceptance and commitment therapy (ACT) with enhanced usual care for adolescents with functional somatic syndromes: a study protocol for a randomised trial

Karen Hansen Kallesøe,1 Andreas Schröder,1 Rikard K Wicksell,2 Per Fink,1 Eva Ørnbøl,1 and Charlotte Ulrikka Rask1,3

BMJ Open. 2016; 6(9): e012743.
Published online 2016 Sep 15. doi: 10.1136/bmjopen-2016-012743

Abstract
Introduction
Functional somatic syndromes (FSS) are common in adolescents, characterised by severe disability and reduced quality of life. Behavioural treatments such as acceptance and commitment therapy (ACT) has shown promising results in children and adolescents with FSS, but has focused on specific syndromes such as functional pain. The current study will compare the efficacy of group-based ACT with that of enhanced usual care (EUC) in adolescents with a range of FSS operationalised by the unifying construct of multiorgan bodily distress syndrome (BDS).

Methods and analysis
A total of 120 adolescents aged 15–19 and diagnosed with multiorgan BDS, of at least 12 months duration, will be assessed and randomised to either: (1) EUC: a manualised consultation with a child and adolescent psychiatrist and individualised treatment plan or (2) manualised ACT-based group therapy plus EUC. The ACT programme consists of 9 modules (ie, 27 hours) and 1 follow-up meeting (3 hours). The primary outcome is physical health, assessed by an Short Form Health Survey (SF-36) aggregate score 12 months after randomisation. Secondary outcomes include self-reported symptom severity, symptom interference, depression and anxiety, illness worry, perceived stress and global improvement; as well as objective physical activity and bodily stress response measured by heart rate variability, hair cortisol and inflammatory biomarkers. Process measures are illness perception, illness-related behaviour and psychological flexibility.

Ethics and dissemination
The study is conducted in accordance with Helsinki Declaration II. Approval has been obtained from the Science Ethics Committee of the Central Denmark Region and the Danish Data Protection. The results will be sought to be published according to the CONSORT statement in peer-reviewed journals.

Discussion
This is one of the first larger randomised clinical trials evaluating the effect of a group-based intervention for adolescents with a range of severe FSS.

Trial registration number
NCT02346071 https://clinicaltrials.gov/ct2/show/NCT02346071; Pre-results.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030556/

:depressed::vomit::cry::mad::eek: